In a press release, Lilly chair and CEO David A. Ricks said, “Lilly's optimism about the potential of our pipeline across ...

Ron Lanton, Partner, Lanton Law, discusses the legal and industry challenges posed by recent National Institute of Health budget cuts, diversity bans in clinical trials, and pharmaceutical supply ...

FP008 is designed for patients with solid tumors that have not responded to existing immunotherapies targeting PD-1.

The Phase III SERENA-6 trial is the first global trial to use a circulating tumor DNA-guided approach to detect endocrine ...

The Alpha Cognition executive discusses recent developments that positively impact the upcoming launch for ZUNVEYL.

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy ...

Zimmer Biomet Holdings launched a new educational campaign targeting people living with joint pain. 1 The campaign is ...

Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor ...

FDA recently announced new safety requirements for DPD screening in cancer patients. Kristine Ashcraft, founder and CEO of ...

Surgifort is the first FDA-approved human milk-based fortifier specifically designed for term infants recovering from ...

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing ...

The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...